These results demonstrate that inhibiting the expression of either ABCB1 or ABCC11 restored the sensitivity to eribulin, although the degree of restoration varied depending on the cell line, indicating that ABCB1 and ABCC11 are involved in the development of eribulin resistance in these breast cancer cells. This evidence concerns the gene ABCB1 and breast carcinoma.